Skip to content
Laurent CapitalMergers & Acquisitions

Healthcare Services

We advise owners of business-to-business healthcare companies, from revenue cycle management and outsourced services to laboratories and medical products distribution. Our processes address the regulatory, reimbursement and client-concentration questions that healthcare buyers examine first.

Subsectors we cover

  • Revenue cycle management
  • Medical coding & billing
  • Outsourced clinical & support services
  • Clinical & reference laboratories
  • Medical device & supply distribution
  • Pharmacy services
  • Healthcare staffing
  • Healthcare IT services
  • Life sciences & CRO services
  • Biomedical equipment services

Themes driving M&A

Provider outsourcing

Hospitals, health systems and physician groups face sustained labor and margin pressure, and increasingly outsource functions such as revenue cycle, coding and equipment management. Vendors with documented outcomes and long client relationships benefit directly.

Reimbursement scrutiny

Changes in reimbursement, prior authorization and payer audit activity affect providers and the vendors that serve them. Buyers favor businesses whose revenue is tied to contracted client fees rather than directly to reimbursement rates.

Technology in administrative workflows

Automation and AI are being applied to coding, claims, eligibility and documentation. Service providers that combine technology with deep domain expertise are well positioned, and larger firms acquire them to modernize their own offerings.

Life sciences outsourcing

Pharmaceutical and medical device companies continue to outsource research support, testing, regulatory and commercial functions. Specialized providers with strong quality and compliance records attract interest from both strategic and sponsor buyers.

Our perspective

Healthcare buyers are drawn to the sector’s steady demand and the scale of the outsourcing opportunity, but they approach every transaction with caution about regulation and reimbursement. A business that has organized its compliance documentation, understands its exposure to payer changes and can show the outcomes it delivers to clients will move through diligence with fewer surprises and less pressure on price.

Regulatory diligence is central

Healthcare buyers will review licenses, accreditations, privacy and security practices, billing compliance and any participation in government programs. Issues in these areas can delay or derail a transaction, or lead to escrows and special indemnities that reduce what the owner actually receives. We help owners assess their position early, typically alongside healthcare regulatory counsel, so that gaps are addressed before buyers see them.

What buyers examine

  • HIPAA compliance, business associate agreements and data security practices
  • Licensure, accreditation and inspection history, including CLIA and CAP where relevant
  • Billing and coding accuracy, audit results and any payer disputes
  • Exposure to Medicare, Medicaid and commercial reimbursement changes
  • Client contracts, renewal history and change-of-control provisions
  • Referral relationships and fair market value arrangements under Stark and Anti-Kickback rules

Positioning the business

B2B healthcare companies are often valued more like business services or technology companies than like providers, provided their revenue is contracted and not directly dependent on reimbursement. Presenting the business on that basis, with clear client economics and documented outcomes, helps buyers apply the right valuation framework. Where reimbursement exposure exists, a clear analysis of its scale and sensitivity is better than leaving buyers to estimate it themselves, because buyers who estimate tend to assume the worst.

Client concentration deserves similar treatment. Many B2B healthcare vendors serve a limited number of health systems or sponsors, and a single large contract can represent a meaningful share of revenue. Buyers will ask about contract terms, renewal dates and the depth of relationships beyond one executive sponsor. A documented account history with several points of contact reassures them.

Our sourcing platform maps healthcare services platforms, distributors and technology companies by capability and client segment. That helps identify buyers with a specific strategic reason to acquire, including those serving the same health systems or life sciences clients with complementary services.

What buyers pay a premium for

  1. 1

    Contracted client relationships

    Multi-year service agreements with health systems, physician groups or life sciences companies and a strong renewal history.

  2. 2

    Limited direct reimbursement risk

    Revenue tied to client fees rather than to government or commercial payer reimbursement rates.

  3. 3

    Compliance track record

    A clean audit history and mature HIPAA, CLIA, FDA or other compliance programs appropriate to the business.

  4. 4

    Measurable client outcomes

    Documented improvements in collections, turnaround times or cost that support retention and pricing.

  5. 5

    Scalable operations

    Technology, standardized processes and a workforce model that support growth without a proportional increase in cost.

Active buyers

Strategic acquirers

Larger healthcare services and technology companies acquire to add capabilities, client relationships or geographic reach. They value specialized expertise that strengthens their position with health systems or life sciences clients.

Private equity platforms

Healthcare-focused sponsors look for contracted, recurring revenue, defensible niches and limited reimbursement exposure. They conduct rigorous regulatory diligence and place real value on strong compliance infrastructure.

Add-on buyers

Sponsor-backed platforms in revenue cycle, laboratory services or distribution acquire smaller firms to add clients, density or specialized capabilities. They can offer founders a rollover into a larger, better-capitalized business.

Metrics we prepare and defend

  • Revenue by client, payer and service line
  • Client retention and contract renewals
  • Reimbursement and payer mix exposure
  • Days sales outstanding and collections
  • Compliance and audit history
  • Labor cost and productivity per FTE

Selected transactions

Healthcare Services

Family-owned medical device distributor

has been acquired by

a private equity–backed healthcare platform

Exclusive sell-side advisor

2025

Questions owners ask

How do buyers view revenue that depends on reimbursement rates?

Reimbursement-dependent revenue is not a barrier, but buyers will assess its sensitivity to rate changes and policy shifts. Revenue based on contracted fees with providers or life sciences companies is generally viewed as more predictable. We help quantify reimbursement exposure so buyers can price it rather than discount for uncertainty.

What compliance issues commonly arise in healthcare transactions?

Common findings include incomplete business associate agreements, outdated HIPAA security risk assessments, licensing lapses in individual states and billing practices that do not match documentation. Most can be remedied if identified early. We generally recommend a pre-sale compliance review with healthcare counsel.

Will my clients need to consent to a sale?

Some contracts with health systems include assignment or change-of-control provisions that require notice or consent. Buyers will want to understand these early. We review contracts during preparation and plan client communications so that consent processes do not delay closing or put relationships at risk.

Related insights

Exploring a transaction in healthcare services?

Conversations with Laurent Capital are confidential and carry no obligation. A senior member of the firm responds to every inquiry within one business day.

Start a confidential conversation

(650) 999-9845|info@laurent.capital